Kinkead et al.
2018
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer
Gabrilovich et al.
1996
Dendritic cells in antitumor immune responses: I. Defective antigen presentation in tumor-bearing hosts
Palucka et al.
2007
Taming cancer by inducing immunity via dendritic cells
Liu et al.
2022
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Townsend et al.
1993
Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
Ahlers et al.
2001
High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection
Rapoport et al.
2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Wen et al.
1998
Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma.
Yuan et al.
2009
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma
CN113613673A
(zh )
2021-11-05
用于治疗胰腺癌的药物组合物
JP2021502414A5
(https= )
2021-12-16
Aspord et al.
2012
HLA-A* 0201+ plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients
Connerotte et al.
2008
Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities
Faure et al.
2009
Long‐lasting cross‐presentation of tumor antigen in human DC
Knutson et al.
2004
IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion
JP2024538129A5
(https= )
2025-10-17
TW202003030A
(zh )
2020-01-16
新抗原表位疫苗及免疫刺激組合物及方法
Palucka et al.
2009
Harnessing dendritic cells to generate cancer vaccines
JP2008526763A
(ja )
2008-07-24
予防又は治療目的のｍｈｃクラスｉ拘束性エピトープに対する免疫応答の誘導、増強及び保持方法
Llopiz et al.
2021
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
ES2340358T3
(es )
2010-06-02
Uso de lineas celulares alogenicas para cargar celulas que presentan antigenos para elicitar respuestas inmunes.
Kogo et al.
2017
Suppression of murine tumour growth through CD 8+ cytotoxic T lymphocytes via activated DEC‐205+ dendritic cells by sequential administration of α‐galactosylceramide in vivo
Cohen et al.
1993
Use of interleukin-7, interleukin-2, and interferon-γ to propagate CD4+ T cells in culture with maintained antigen specificity
Goldman et al.
2000
Effective elimination of lung metastases induced by tumor cells treated with hydrostatic pressure and N-acetyl-L-cysteine
Kirkpatrick et al.
2024
Deciphering CD4+ T cell‐mediated responses against cancer